Skip to main content
SpringerLink
Log in

Melanoma of the Ear Canal and Temporal Bone

  • Chapter
  • First Online:
Temporal Bone Cancer

  • 731 Accesses

Abstract

Melanoma comprises about 5% of cutaneous malignancies and its incidence is increasing. While the external ear is a common site of melanoma for the head and neck, the ear canal, middle ear, inner ear, and cerebellopontine angle are rare sites for melanoma to occur primarily. These sites can also be involved with metastatic melanoma. This chapter discusses the evaluation and management of melanoma that affects the ear canal and temporal bone.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Board PDQATE. Melanoma treatment (PDQ(R)): Health professional version. PDQ cancer information summaries. National Cancer Institute: Bethesda; 2017.

    Google Scholar 

  2. Schmerber S, Righini C, Soriano E, et al. [The outcome of treatments for carcinoma of the external auditory canal]. Rev Laryngol Otol Rhinol (Bord). 2005;126(3):165–70.

    Google Scholar 

  3. Conley J, Schuller DE. Malignancies of the ear. Laryngoscope. 1976;86(8):1147–63.

    Article  CAS  PubMed  Google Scholar 

  4. Altuna Mariezkurrena X, Henriquez Alarcon M, Vea Orte JC, Algaba Guimera J. [Malignant tumors of external ear. Review of cases in 1991-2001]. An Otorrinolaringol Ibero Am. 2003;30(1):83–94.

    Google Scholar 

  5. Stang A, Pukkala E, Sankila R, Soderman B, Hakulinen T. Time trend analysis of the skin melanoma incidence of Finland from 1953 through 2003 including 16,414 cases. Int J Cancer. 2006;119(2):380–4.

    Article  CAS  PubMed  Google Scholar 

  6. Green AC, Kimlin M, Siskind V, Whiteman DC. Hypothesis: hair cover can protect against invasive melanoma on the head and neck (Australia). Cancer Causes Control. 2006;17(10):1263–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Ravin AG, Pickett N, Johnson JL, Fisher SR, Levin LS, Seigler HF. Melanoma of the ear: treatment and survival probabilities based on 199 patients. Ann Plast Surg. 2006;57(1):70–6.

    Article  CAS  PubMed  Google Scholar 

  8. Ringborg U, Afzelius LE, Lagerlof B, et al. Cutaneous malignant melanoma of the head and neck. Analysis of treatment results and prognostic factors in 581 patients: a report from the Swedish Melanoma Study Group. Cancer. 1993;71(3):751–8.

    Article  CAS  PubMed  Google Scholar 

  9. Fisher SR. Cutaneous malignant melanoma of the head and neck. Laryngoscope. 1989;99(8 Pt 1):822–36.

    CAS  PubMed  Google Scholar 

  10. Thorn M, Ponten F, Bergstrom R, Sparen P, Adami HO. Clinical and histopathologic predictors of survival in patients with malignant melanoma: a population-based study in Sweden. J Natl Cancer Inst. 1994;86(10):761–9.

    Article  CAS  PubMed  Google Scholar 

  11. Byers RM, Smith JL, Russell N, Rosenberg V. Malignant melanoma of the external ear. Review of 102 cases. Am J Surg. 1980;140(4):518–21.

    Article  CAS  PubMed  Google Scholar 

  12. Hawkes JE, Truong A, Meyer LJ. Genetic predisposition to melanoma. Semin Oncol. 2016;43(5):591–7.

    Article  CAS  PubMed  Google Scholar 

  13. Ozturk O, Baglam T, Uneri C, Kullu S. Primary malignant melanoma of the middle ear mucosa: a case report. Kulak Burun Bogaz Ihtis Derg. 2006;16(2):83–6.

    PubMed  Google Scholar 

  14. Whinney D, Kitchen N, Revesz T, Brookes G. Primary malignant melanoma of the cerebellopontine angle. Otol Neurotol. 2001;22(2):218–22.

    Article  CAS  PubMed  Google Scholar 

  15. Milbrath MM, Campbell BH, Madiedo G, Janjan NA. Malignant melanoma of the external auditory canal. Am J Clin Oncol. 1998;21(1):28–30.

    Article  CAS  PubMed  Google Scholar 

  16. Amando Garcia L, Suarez Nieto C, Madrigal Rubiales B, Garcia Garcia J. [External ear melanoma]. Acta Otorrinolaringol Esp. 2003;54(2):89–93.

    Google Scholar 

  17. Langman A, Yarington T, Patterson SD. Malignant melanoma of the external auditory canal. Otolaryngol Head Neck Surg. 1996;114(4):645–8.

    Article  CAS  PubMed  Google Scholar 

  18. Hynes B, Lubynski RA, Hynes B. Malignant melanoma of the external ear canal: a rare case. J Otolaryngol. 2004;33(6):401–3.

    Article  PubMed  Google Scholar 

  19. Banerjee AR, Meikle D, Dawes PJ, Deans JA. Malignant melanoma of the external auditory meatus. Clin Oncol (R Coll Radiol). 1993;5(4):255–6.

    Article  CAS  Google Scholar 

  20. Kang S, Barnhill RL, Graeme-Cook F, Randolph G, Nadol JB, Sober AJ. Primary malignant melanoma of the external auditory canal: a case report with presentation as an aural polyp. Am J Otol. 1992;13(2):194–6.

    CAS  PubMed  Google Scholar 

  21. Shih L, Crabtree JA. Carcinoma of the external auditory canal: an update. Laryngoscope. 1990;100(11):1215-1218.

    Article  Google Scholar 

  22. Sambe S, Kobayashi K, Asakura K, Kataura A. [A case of malignant melanoma in the external auditory canal followed by systemic vasculitis]. Nippon Jibiinkoka Gakkai Kaiho. 1985;88(4):455–62.

    Article  CAS  PubMed  Google Scholar 

  23. Olariu B, Olariu D, Jianu S, Albastroiu F, Ciuchi V, Laky D. [Malignant melanoma of the external auditory canal treated by cryotherapy]. Rev Chir Oncol Radiol. 1984;29(4):299–311.

    Google Scholar 

  24. Urpegui Garcia A, Lahoz Zamarro T, Muniesa Soriano JA, et al. [Malignant melanoma of the middle ear, a rare site]. Acta Otorrinolaringol Esp. 1999;50(7):559–62.

    Google Scholar 

  25. Xenellis J, Mountricha A, Maragoudakis P, et al. A histological examination in the cases of initial diagnosis as chronic otitis media with a polypoid mass in the external ear canal. Auris Nasus Larynx. 2011;38(3):325–8.

    Article  PubMed  Google Scholar 

  26. Khan I, Mohamad S, Shakeel M, Jaramillo MJ. Aural metastasis from a nasal malignant melanoma: case report with literature review. J Laryngol Otol. 2011;125(12):1290–3.

    Article  CAS  PubMed  Google Scholar 

  27. Walther EK, Krick T. [Malignant melanoma of the temporal bone]. Laryngorhinootologie. 1993;72(1):48–50.

    Google Scholar 

  28. Hannan SA, Parikh A. Malignant melanoma of the external ear canal. Lancet. 2006;368(9548):1680.

    Article  PubMed  Google Scholar 

  29. Kazikdas KC, Onal K, Kuehnel TS, Ozturk T. An intradermal nevus of the external auditory meatus. Eur Arch Otorhinolaryngol. 2006;263(3):253–5.

    Article  PubMed  Google Scholar 

  30. EL MK Jr, Holmes WF, Harwick R. Primary melanoma of the middle ear. Laryngoscope. 1984;94(11 Pt 1):1459–60.

    Google Scholar 

  31. Sherman IW, Swift AC, Haqqani MT. Primary mucosal malignant melanoma of the middle ear. J Laryngol Otol. 1991;105(12):1061–4.

    Article  CAS  PubMed  Google Scholar 

  32. Banerjee A, Meikle D. Malignant melanoma of the middle ear. J Laryngol Otol. 1992;106(6):581.

    Article  CAS  PubMed  Google Scholar 

  33. Folz BJ, Niemann AM, Lippert BM, Hauschild A, Werner JA. [Mucous membrane melanomas of the upper aerodigestive tract. An analysis of 34 cases]. Laryngorhinootologie. 1997;76(5):289–94.

    Google Scholar 

  34. Oueslati Z, Touati S, Gritli S, et al. [Mucous malignant melanoma of the neck and face. Experience at the Salah Azaiz institute (Tunis)]. Rev Laryngol Otol Rhinol (Bord). 2001;122(4):237–40.

    Google Scholar 

  35. Uchida M, Matsunami T. Malignant amelanotic melanoma of the middle ear. Arch Otolaryngol Head Neck Surg. 2001;127(9):1126–8.

    Article  CAS  PubMed  Google Scholar 

  36. Luo H, Liang JJ, Jiang Y. [Primary malignant melanoma of the middle ear and mastoid: a case report]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2008;43(11):865–6.

    Google Scholar 

  37. Curry JM, Kung BC, Willcox TO Jr. Malignant melanoma of the middle ear. Otolaryngol Head Neck Surg. 2007;136(5):856–7.

    Article  PubMed  Google Scholar 

  38. Tywonczuk-Szulc M, Kibilda B. Malignant melanoma of the auditory tube. Otolaryngol Pol. 2007;61(3):335–8.

    Article  PubMed  Google Scholar 

  39. Racic G, Kurtovic D, Roje Z, Tomic S, Dogas Z. Primary mucosal melanoma of the eustachian tube. Eur Arch Otorhinolaryngol. 2004;261(3):139–42.

    Article  PubMed  Google Scholar 

  40. Baek SJ, Song MH, Lim BJ, Lee WS. Mucosal melanoma arising in the eustachian tube. J Laryngol Otol. 2006;120(3):E17.

    Article  PubMed  Google Scholar 

  41. Lai CC, Tsay SH, Ho CY. Malignant melanoma of the eustachian tube. J Laryngol Otol. 2001;115(7):567–9.

    Article  CAS  PubMed  Google Scholar 

  42. Sakaki M, Shek TW, Hirokawa M, et al. Melanotic oncocytic metaplasia of the nasopharynx: a report of seven cases and review of the literature. Virchows Arch. 2004;444(4):345–9.

    Article  PubMed  Google Scholar 

  43. Piedra MP, Scheithauer BW, Driscoll CL, Link MJ. Primary melanocytic tumor of the cerebellopontine angle mimicking a vestibular schwannoma. Neurosurgery. 2006;59(1):E206.

    Article  PubMed  Google Scholar 

  44. Rodriguez-Zuniga, Milton Jose Max, Pablo Humberto Effio-Iman. Primary cerebellopontine angle melanoma: Case Report and Systematic Review. Polish Ann Med.2017;24(2):268–75.

    Article  Google Scholar 

  45. Kingdom TT, Lalwani AK, Pitts LH. Isolated metastatic melanoma of the cerebellopontine angle: case report. Neurosurgery. 1993;33(1):142–4.

    CAS  PubMed  Google Scholar 

  46. Anderson TD, Weber RS, Guerry D, et al. Desmoplastic neurotropic melanoma of the head and neck: the role of radiation therapy. Head Neck. 2002;24(12):1068–71.

    Article  PubMed  Google Scholar 

  47. Beenken S, Byers R, Smith JL, Goepfert H, Shallenberger R. Desmoplastic melanoma. Histologic correlation with behavior and treatment. Arch Otolaryngol Head Neck Surg. 1989;115(3):374–9.

    Article  CAS  PubMed  Google Scholar 

  48. Pathak I, O’Brien CJ, Petersen-Schaeffer K, et al. Do nodal metastases from cutaneous melanoma of the head and neck follow a clinically predictable pattern? Head Neck. 2001;23(9):785–90.

    Article  CAS  PubMed  Google Scholar 

  49. O’Brien CJ, McNeil EB, McMahon JD, Pathak I, Lauer CS. Incidence of cervical node involvement in metastatic cutaneous malignancy involving the parotid gland. Head Neck. 2001;23(9):744–8.

    Article  PubMed  Google Scholar 

  50. Wick MR. Cutaneous melanoma: a current overview. Semin Diagn Pathol. 2016;33(4):225–41.

    Article  PubMed  Google Scholar 

  51. Amaral T, Sinnberg T, Meier F, et al. MAPK pathway in melanoma part II-secondary and adaptive resistance mechanisms to BRAF inhibition. Eur J Cancer. 2017;73:93–101.

    Article  CAS  PubMed  Google Scholar 

  52. Amann VC, Ramelyte E, Thurneysen S, et al. Developments in targeted therapy in melanoma. Eur J Surg Oncol. 2017;43(3):581–93.

    Article  CAS  PubMed  Google Scholar 

  53. Wagner JD, Park HM, Coleman JJ 3rd, Love C, Hayes JT. Cervical sentinel lymph node biopsy for melanomas of the head and neck and upper thorax. Arch Otolaryngol Head Neck Surg. 2000;126(3):313–21.

    Article  CAS  PubMed  Google Scholar 

  54. Carlson GW, Murray DR, Greenlee R, et al. Management of malignant melanoma of the head and neck using dynamic lymphoscintigraphy and gamma probe-guided sentinel lymph node biopsy. Arch Otolaryngol Head Neck Surg. 2000;126(3):433–7.

    Article  CAS  PubMed  Google Scholar 

  55. Wey PD, De La Cruz C, Goydos JS, Choi ML, Borah GL. Sentinel lymph node mapping in melanoma of the ear. Ann Plast Surg. 1998;40(5):506–9.

    Article  CAS  PubMed  Google Scholar 

  56. Balch CM, Gershenwald JE, S-J S, et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol. 2009;27(36):6199–206.

    Article  PubMed  PubMed Central  Google Scholar 

  57. Lens M, Dawes M, Newton-Bishop J, Goodacre T. Tumour thickness as a predictor of occult lymph node metastases in patients with stage I and II melanoma undergoing sentinel lymph node biopsy. Br J Surg. 2002;89(10):1223–7.

    Article  CAS  PubMed  Google Scholar 

  58. Tardelli E, Mazzarri S, Rubello D, et al. Sentinel lymph node biopsy in cutaneous melanoma: standard and new technical procedures and clinical advances. A systematic review of the literature. Clin Nucl Med. 2016;41(12):e498–507.

    Article  PubMed  Google Scholar 

  59. Yang E, Linthicum FH Jr. Metastatic melanoma. Otol Neurotol. 2005;26(4):821–2.

    Article  PubMed  Google Scholar 

  60. Adler NR, Haydon A, McLean CA, Kelly JW, Mar VJ. Metastatic pathways in patients with cutaneous melanoma. Pigment Cell Melanoma Res. 2017;30(1):13–27.

    Article  PubMed  Google Scholar 

  61. Deroee AF, Joglekar S, Paparella MM. Malignant melanoma metastasis to temporal bone. Otol Neurotol. 2009;30(2):248–9.

    Article  PubMed  Google Scholar 

  62. Navarrete CM, Ruah CB, Schachern P, Paparella MM. Normal and metastatic melanin in the temporal bone. Am J Otolaryngol. 1995;16(1):33–9.

    Article  CAS  PubMed  Google Scholar 

  63. Kojima C, Iino Y, Nakamoto Y, Toriyama M. [Histopathological studies of temporal bones of patients with malignant melanoma]. Nippon Jibiinkoka Gakkai Kaiho. 1997;100(6):655–62.

    Article  CAS  PubMed  Google Scholar 

  64. Conley J, Juarbe C, Patow CA, Angel MF. Metastatic melanoma to the facial nerve. Plast Reconstr Surg. 1991;87(2):341–5.

    Article  CAS  PubMed  Google Scholar 

  65. Cohen JV, Tawbi H, Margolin KA, et al. Melanoma central nervous system metastases: current approaches, challenges, and opportunities. Pigment Cell Melanoma Res. 2016;29(6):627–42.

    Article  PubMed  PubMed Central  Google Scholar 

  66. Arriaga MA, Lo WW, Brackmann DE. Metastatic melanoma to the cerebellopontine angle. Clinical and imaging characteristics. Arch Otolaryngol Head Neck Surg. 1995;121(9):1052–6.

    Article  CAS  PubMed  Google Scholar 

  67. Brackmann DE, Doherty JK. CPA melanoma: diagnosis and management. Otol Neurotol. 2007;28(4):529–37.

    Article  PubMed  Google Scholar 

  68. Delerue O, Destee A, Devos P. Bilateral metastases in the cerebellopontine angle. J Neurol Neurosurg Psychiatry. 1991;54(6):562.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  69. Cervio A, Saadia D, Nogues M, Bas C, Coppola F. Metastatic melanoma within the internal auditory canal: a case report. Am J Otolaryngol. 1999;20(4):263–5.

    Article  CAS  PubMed  Google Scholar 

  70. Garcia Gonzalez LA, Redondo Ventura F. [Metastases in both internal auditive meatus of nasosinusal melanoma]. An Otorrinolaringol Ibero Am. 2005;32(6):537–44.

    Google Scholar 

  71. Jacob A, Brightman RP, Welling DB. Bilateral cerebellopontine angle metastatic melanoma: A case report. Ear Nose Throat J. 2007;86(7):388–90.

    PubMed  Google Scholar 

  72. Yang AS, Bird P. Intracranial metastatic melanoma presenting with bilateral hearing loss. Otol Neurotol. 2009;30(2):243–4.

    Article  PubMed  Google Scholar 

  73. Fort M, Guet S, Husheng S, Calitchi E, Belkacemi Y. Role of radiation therapy in melanomas: systematic review and best practice in 2016. Crit Rev Oncol Hematol. 2016;99:362–75.

    Article  PubMed  Google Scholar 

  74. Ethun CG, Delman KA. The importance of surgical margins in melanoma. J Surg Oncol. 2016;113(3):339–45.

    Article  PubMed  Google Scholar 

  75. O’Brien CJ, Coates AS, Petersen-Schaefer K, et al. Experience with 998 cutaneous melanomas of the head and neck over 30 years. Am J Surg. 1991;162(4):310–4.

    Article  PubMed  Google Scholar 

  76. Bonnen MD, Ballo MT, Myers JN, et al. Elective radiotherapy provides regional control for patients with cutaneous melanoma of the head and neck. Cancer. 2004;100(2):383–9.

    Article  PubMed  Google Scholar 

  77. Agrawal S, Kane JM, Guadagnolo BA, Kraybill WG, Ballo MT. The benefits of adjuvant radiation therapy after therapeutic lymphadenectomy for clinically advanced, high-risk, lymph node-metastatic melanoma. Cancer. 2009;115(24):5836–44.

    Article  PubMed  Google Scholar 

  78. O’Brien CJ, Petersen-Schaefer K, Stevens GN, et al. Adjuvant radiotherapy following neck dissection and parotidectomy for metastatic malignant melanoma. Head Neck. 1997;19(7):589–94.

    Article  PubMed  Google Scholar 

  79. Ballo MT, Garden AS, Myers JN, et al. Melanoma metastatic to cervical lymph nodes: can radiotherapy replace formal dissection after local excision of nodal disease? Head Neck. 2005;27(8):718–21.

    Article  PubMed  Google Scholar 

  80. Chang DT, Amdur RJ, Morris CG, Mendenhall WM. Adjuvant radiotherapy for cutaneous melanoma: comparing hypofractionation to conventional fractionation. Int J Radiat Oncol Biol Phys. 2006;66(4):1051–5.

    Article  PubMed  Google Scholar 

  81. Filippi AR, Fava P, Badellino S, Astrua C, Ricardi U, Quaglino P. Radiotherapy and immune checkpoints inhibitors for advanced melanoma. Radiother Oncol. 2016;120(1):1–12.

    Article  CAS  PubMed  Google Scholar 

  82. Lens MB, Dawes M. Interferon alfa therapy for malignant melanoma: a systematic review of randomized controlled trials. J Clin Oncol. 2002;20(7):1818–25.

    Article  CAS  PubMed  Google Scholar 

  83. Eton O, Legha SS, Bedikian AY, et al. Sequential biochemotherapy versus chemotherapy for metastatic melanoma: results from a phase III randomized trial. J Clin Oncol. 2002;20(8):2045–52.

    Article  CAS  PubMed  Google Scholar 

  84. Xin Y, Huang Q, Zhang P, et al. Meta-analysis of the safety and efficacy of interferon combined with Dacarbazine versus Dacarbazine alone in cutaneous malignant melanoma. Medicine. 2016;95(16):e3406.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  85. Pasquali S, Chiarion-Sileni V, Rossi CR, Mocellin S. Immune checkpoint inhibitors and targeted therapies for metastatic melanoma: a network meta-analysis. Cancer Treat Rev. 2017;54:34–42.

    Article  CAS  PubMed  Google Scholar 

  86. Amaral T, Sinnberg T, Meier F, et al. The mitogen-activated protein kinase pathway in melanoma part I— activation and primary resistance mechanisms to BRAF inhibition. Eur J Cancer. 2017;73:85–92.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Head and Neck Surgery, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA

    Paul W. Gidley M.D., F.A.C.S.

Authors
  1. Paul W. Gidley M.D., F.A.C.S.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Paul W. Gidley M.D., F.A.C.S. .

Editor information

Editors and Affiliations

  1. Department of Head and Neck Surgery, Otology-Neurotology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA

    Paul W. Gidley

  2. Department of Neurosurgery, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA

    Franco DeMonte

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Gidley, P.W. (2018). Melanoma of the Ear Canal and Temporal Bone. In: Gidley, P., DeMonte, F. (eds) Temporal Bone Cancer. Springer, Cham. https://doi.org/10.1007/978-3-319-74539-8_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-74539-8_8

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-74538-1

  • Online ISBN: 978-3-319-74539-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation